Navigation Links
Herceptin and Tykerb effective against a subset of gastric cancers
Date:3/3/2010

previously progressed while on the single drug.

Tykerb was tested at UCLA for use in gastric cancers, first in cell lines and animal models, and was shown to be effective in cancers with HER2 amplification. A randomized Phase III clinical trial testing Tykerb with chemotherapy in HER2 amplified gastric cancer patients opened recently and is currently enrolling patients.

Herceptin also has been successfully tested in HER2 amplified gastric cancer patients, Wainberg said, and is expected to be approved for that use by the U.S. Food & Drug Administration within the next six months.

Wainberg said this is the first time that Herceptin and Tykerb have been paired to fight this subset of gastric cancers.

"In our animal models, the mice that received both Herceptin and Tykerb had their tumors shrink down to virtually nothing," Wainberg said. "This suggests that in those tumors that are dependent on HER2 for growth, this combination may be a very effective treatment. The combination of therapies was much better than either Herceptin or Tykerb alone."

The dual blockade works using two mechanisms, blocking cell signaling from inside the cell as well as on the cell's surface. Herceptin, an antibody, blocks growth signals sitting on the surface of the cancer cell, while Tykerb, a tyrosine kinase inhibitor, works from inside the cell to block the signaling that results in out of control growth of the cancer cells.

If just one therapy is used, the cancer cells often can find ways to get around the single blockade, Wainberg said. Using the combination provides a double whammy, and makes it much more difficult for the cancer to circumvent treatment. Herceptin is administered by intravenous infusion, while Tykerb is taken in pill form.

The Jonsson Cancer Center study offers further proof that molecularly targeted therapies those that hone in on what is broken in the cancer cell and leave the healthy tissue unharm
'/>"/>

Contact: Kim Irwin
kirwin@mednet.ucla.edu
310-206-2805
University of California - Los Angeles
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Herceptin Again Proves Mettle Against Breast Cancer
2. Mayo Clinic researchers say breast cancer survival improves Herceptin used with chemotherapy
3. Chemo With Herceptin May Be Best for Some Breast Cancers
4. Biosimilars of Rituxan, MabThera, Herceptin and Erbitux will Erode $8.2 Billion in U.S. and European Sales in 2018
5. Routine Testing Would Improve Herceptin Use in Breast Cancer
6. Mathematical modeling predicts response to Herceptin
7. If Herceptin is Approved in Combination With Other Emerging Therapies it Will be in a Position to Retain Patient Share From Tykerb/Tyverb for the Treatment of HER2-Positive Breast Cancer
8. Xeloda(R), Taxotere(R) and Herceptin(R) Combination Study Suggests Clinical Benefit in Invasive Breast Cancer with Shortened Treatment Cycle
9. Herceptin helps women with multiple chromosomes containing HER2 gene, study finds
10. GSK Submits TYVERB(R)/TYKERB(R) (lapatinib) for First-Line Treatment of Metastatic Breast Cancer in Europe, US
11. Combination of TYKERB(R) (lapatinib) Plus Letrozole Demonstrated Significant Improvement in Delaying Disease Progression for HER2+/ErbB2+ Post-Menopausal Metastatic Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... 2015 , ... Women fear developing Alzheimer's disease more than having a heart ... stroke are treatable, but there is little an individual can do to arrest the ... a clinical trial, reports the July 2015 Harvard Women's Health Watch . , ...
(Date:7/28/2015)... ... , ... A new study published by HealthDay News on June 24, 2015, ... a possible new treatment option for people living with fibromyalgia – hyperbaric oxygen therapy ... five per week, patients experienced a significant decrease in pain, fatigue, and other symptoms ...
(Date:7/28/2015)... IN (PRWEB) , ... July 28, 2015 , ... Most ... released from the 2014 UBA Health Plan Survey shows a significant increase in the ... major increases in corresponding median copays -- a trend that is expected to continue, ...
(Date:7/28/2015)... ... July 28, 2015 , ... PeopleKeys ... the regional winner of the EY Entrepreneur of the Year award. The award ... of home healthcare, and the innovative work they have done in incorporating new ...
(Date:7/28/2015)... Maryland (PRWEB) , ... July 28, 2015 , ... Maryland ... (MBSP) – and, along with it, more service offerings, updated treatment techniques, and ... leading authority for pain management and minimally invasive surgical treatment of brain and spine ...
Breaking Medicine News(10 mins):Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 3Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 2Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 3Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 2Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 3Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 4Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 5Health News:Receiving Recognition for Compassionate Care and Innovative Processes: Celtic Healthcare CEO Arnie Burchianti Wins Regional EY Entrepreneur of the Year Award 2Health News:Receiving Recognition for Compassionate Care and Innovative Processes: Celtic Healthcare CEO Arnie Burchianti Wins Regional EY Entrepreneur of the Year Award 3Health News:Maryland Brain & Spine Announces New Specialty, New Name 2Health News:Maryland Brain & Spine Announces New Specialty, New Name 3Health News:Maryland Brain & Spine Announces New Specialty, New Name 4
... discover gender differences that explain the aging inequity ... discovered yet another gender inequity: Women develop more and ... men do. , The disadvantage had long been suspected, ... Dr. Foad Nahai, a plastic surgeon practicing in Atlanta ...
... , , GAINESVILLE, Fla., Dec. 17 Over the last ... scare language that is used by e cigarette opposition in an ... questioning the tactics of these groups when the evidence clearly shows ... to several studies, lab reports and opinions from top medial and ...
... , , HOUSTON, ... Inc., a majority-owned subsidiary of Arrayit Corporation (OTC Bulletin ... for commercialization of its microarray-based OvaDx(TM) Pre-Symptomatic ... late-stage development - the rights to which have been ...
... ... the nearly one-in-three American adults who serve as a family caregiver , ... Arlington, VA (PRWEB) December 17, 2009 -- The ... 2009 , which offers a revealing portrait of the nearly one-in-three American adults who serve ...
... ... Google Local and in front of their local customers by establishing a simple and ... Internet Marketing. , ... New Orleans, LA (PRWEB) December 17, 2009 -- In order to be competitive locally ...
... , ... Using new marketing techniques, life coaching company puts free i-phone & i-touch application ... , ... (PRWEB) December 17, 2009 -- Utah based Attainment Life Management & Coaching is ...
Cached Medicine News:Health News:Mouth Area Wrinkles More in Women Than Men 2Health News:Mouth Area Wrinkles More in Women Than Men 3Health News:Special Interest Deceptions Continue to Rampant About Electronic Cigarettes 2Health News:Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010 2Health News:Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010 3Health News:Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010 4Health News:NAMI Applauds New Report on Caregiving 2Health News:NAMI Applauds New Report on Caregiving 3Health News:New Orleans Based Internet Marketing Is Helping Small Businesses Get a Chance to Shine On the Web 2Health News:Attainment Life Management & Coaching has just Debuted its Free Application for I-Phone and I-Touch Users 2
(Date:7/27/2015)... Colo. , July 27, 2015 /PRNewswire/ ... report financial results for the fourth quarter ... hold a conference call to discuss those ... Squarer, Chief Executive Officer will lead the ... a.m. Eastern TimeToll-Free:(844) 464-3927Toll:(765) 507-2598Pass Code: 68380312 ...
(Date:7/27/2015)... 27, 2015 As per the new ... Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 ... billion in 2014, growing at a CAGR of 13.2% from ... 2021. The global bionics market is growing primarily ... is leading to paralysis or amputation of body parts. In ...
(Date:7/27/2015)... Research and Markets ( http://www.researchandmarkets.com/research/t63pbj/medical_device ) has ... in Asia/Pacific Markets Seminar" conference to their offering. ... market is well established, the next growth area is ... , together with other countries in this region have ... their own medical device regulations. This seminar will provide ...
Breaking Medicine Technology:Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 2Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 3Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 4Medical Device Regulation in Asia/Pacific Markets Seminar: London, UK - 21st, 22nd of September 2015 2
... PDS Biotechnology Corporation today,announced that the company ... the US,National Cancer Institute,s Nanotechnology Characterization Lab ... to filing of,the Investigational New Drug Application. ... biological studies on behalf of the company ...
... completed a clinical safety report from a large Phase ... the excellent,safety profile of IMVAMUNE(R). Within the next few ... to the FDA and this will trigger a USD ... safety,report constitutes a major part of the data package ...
Cached Medicine Technology:PDS Biotechnology Corporation Progresses Development of Nanotechnology Cancer Therapies 2Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE(R) 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: